Medical providers' knowledge and concerns about opioid overdose education and take-home naloxone rescue kits within Veterans Affairs health care medical treatment settings

References

• Centers for Disease Control and Prevention (CDC). Wide-ranging Online Data for Epidemiologic Research (WONDER). Atlanta, GA: CDC, National Center for Health Statistics; 2016. http://wonder.cdc.gov. Accessed June 24, 2016.
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Vital Signs: Overdoses of prescription opioid pain relievers—United States, 1999–2008. MMWR Morb Mortal Wkly Rep. 2011;60:1487–1492.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC). Increases in drug and opioid overdose deaths—United States, 2000–2014. MMWR Morb Mortal Wkly Rep. 2016;64:1378–1382.
   PubMed Web of Science ®Google Scholar
• Compton, WM, Jones CM, Baldwin GT. Relationship between nonmedical prescription-opioid use and heroin use. N Engl J Med. 2016;374:154–163.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Addressing prescription drug abuse in the United States: current activities and future opportunities. https://www.cdc.gov/drugoverdose/pdf/hhs_prescription_drug_abuse_report_09.2013.pdf. Accessed June 24, 2016.
   Google Scholar
• Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10:113–130.
   PubMed Web of Science ®Google Scholar
• Veterans Health Administration, Department of Defense. VA/DoD clinical practice guideline for management of opioid therapy for chronic pain. http://www.healthquality.va.gov/guidelines/Pain/cot/COT_312_Full-er.pdf. Accessed June 27, 2016.
   Google Scholar
• Lim JK, Bratberg JP, Davis CS, Green TC, Walley AY. Prescribe to prevent: overdose prevention and naloxone rescue kits for prescribers and pharmacists. J Addict Med. 2016;10:300–308.
   PubMed Web of Science ®Google Scholar
• Wilder CM, Miller SC, Tiffany E, Winhusen T, Winstanley EL, Stein MD. Risk factors for opioid overdose and awareness of overdose risk among veterans prescribed chronic opioids for addiction or pain. J Addict Dis. 2015;35:42–51.
   Web of Science ®Google Scholar
• Zedler B, Xie L, Wang L, et al. Development of a risk index for serious prescription opioid‐induced respiratory depression or overdose in Veterans' Health Administration patients. Pain Med. 2015;16:1566–1579.
   PubMed Web of Science ®Google Scholar
• Coffin PO, Behar E, Rowe C, et al. Nonrandomized intervention study of naloxone coprescription for primary care patients receiving long-term opioid therapy for pain. Ann Intern Med. 2016.
   PubMed Web of Science ®Google Scholar
• Binswanger IA, Koester S, Mueller SR, Gardner EM, Goddard K, Glanz JM. Overdose education and naloxone for patients prescribed opioids in primary care: a qualitative study of primary care staff. J Gen Intern Med. 2015;30:1837–1844.
   PubMed Web of Science ®Google Scholar
• Matheson C, Pflanz-Sinclair C, Aucott L, et al. Reducing drug related deaths: a pre-implementation assessment of knowledge, barriers and enablers for naloxone distribution through general practice. BMC Fam Pract. 2014;15:1.
   PubMed Web of Science ®Google Scholar
• Seal KH, Cohen G, Waldrop A, Cohen BE, Maguen S, Ren L. Substance use disorders in Iraq and Afghanistan veterans in VA healthcare, 2001–2010: implications for screening, diagnosis and treatment. Drug Alcohol Depend. 2011;116:93–101.
   PubMed Web of Science ®Google Scholar
• Bohnert AS, Ilgen MA Galea S, McCarthy JF, Blow FC. Accidental poisoning mortality among patients in the Department of Veterans Affairs Health System. Med Care. 2011;49:393–396.
   PubMed Web of Science ®Google Scholar
• Oliva EM, Nevedal A, Lewis ET, et al. Patient perspectives on an opioid overdose education and naloxone distribution program in the US Department of Veterans Affairs. Subst Abus. 2015;37:118–126.
   Web of Science ®Google Scholar
• Beletsky L, Ruthazer R, Macalino GE, Rich JD, Tan L, Burris S. Physicians' knowledge of and willingness to prescribe naloxone to reverse accidental opiate overdose: challenges and opportunities. J Urban Health. 2007;84:126–136.
   PubMed Web of Science ®Google Scholar
• Green TC, Bowman SE, Zaller ND, Ray M, Case P, Heimer R. Barriers to medical provider support for prescription naloxone as overdose antidote for lay responders. Subst Use Misuse. 2013;48:558–567.
   PubMed Web of Science ®Google Scholar
• Burris S, Beletsky L, Castagna C, Casey C, Colin C, McLaughlin JM. Stopping an invisible epidemic: legal issues in the provision of naloxone to prevent opioid overdose. Drexel Law Rev. 2009;1:273–339.
   Google Scholar
• Williams AV, Strang J, Marsden J. Development of Opioid Overdose Knowledge (OOKS) and Attitudes (OOAS) Scales for take-home naloxone training evaluation. Drug Alcohol Depend. 2013;132:383–386.
   PubMed Web of Science ®Google Scholar
• Underhill K. Risk-taking and rulemaking: addressing risk compensation behavior through FDA regulation of prescription drugs. Yale J Regul. 2013;30:377–437.
   Google Scholar
• Doe-Simkins M, Quinn E, Xuan Z, et al. Overdose rescues by trained and untrained participants and change in opioid use among substance-using participants in overdose education and naloxone distribution programs: a retrospective cohort study. BMC Public Health. 2014;14:1.
   PubMed Web of Science ®Google Scholar
• Maxwell S, Bigg D, Stanczykiewicz K, Carlberg-Racich S. Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths. J Addict Dis. 2006;25:89–96.
   PubMed Web of Science ®Google Scholar
• Seal KH, Thawley R, Gee L, et al. Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study. J Urban Health. 2005;82:303–311.
   PubMed Web of Science ®Google Scholar
• Wagner KD, Valente TW, Casanova M, et al. Evaluation of an overdose prevention and response training programme for injection drug users in the Skid Row area of Los Angeles, CA. Int J Drug Policy. 2010;21:186–193.
   PubMed Web of Science ®Google Scholar
• Zimet G. Role of naloxone in opioid overdose fatality prevention. FDA Hearing April 12, 2012.
   Google Scholar
• Oliva EM, Bowe T, Tavakoli S, et al. Development and applications of the Veterans Health Administration's Stratification Tool for Opioid Risk Mitigation (STORM) to improve opioid safety and prevent overdose and suicide. Psychiatr Serv. 2017;14:34–49.
   Google Scholar
• Livingston JD, Milne T, Fang ML, Amari E. The effectiveness of interventions for reducing stigma related to substance use disorders: a systematic review. Addiction. 2012;107:39–50.
   PubMed Web of Science ®Google Scholar